Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation

NCT00004176 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00004176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Evaluation of Ethyol as an Esophageal Mucosal Protectant in the Treatment of Limited Disease Small Cell Lung Cancer With Chemotherapy and Twice-Daily Radiation
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
October 31, 1998
Completion date
February 28, 2001
Enrollment
34 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

drug/agent toxicity by tissue/organ, lung cancer, radiation toxicity